Skip to content
ClinCalc Pro
Menu
Topical steroid + local anaesthetic

Hydrocortisone with lidocaine

Brand names: Xyloproct

Hydrocortisone with lidocaine is a topical/rectal preparation (cream, ointment or suppository) combining a corticosteroid with a local anaesthetic, used for short-term symptomatic relief of perianal conditions such as haemorrhoids and proctitis.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Hydrocortisone exerts a local anti-inflammatory and anti-pruritic effect, while lidocaine reversibly blocks neuronal sodium channels to produce local anaesthesia and reduce pain and itching at the application site.

Prescribing in practice

  • Limit treatment to short courses, as prolonged or excessive perianal corticosteroid use can cause skin atrophy and the preparation should be avoided where untreated anal/perianal infection (bacterial, fungal or viral) is present.
  • Apply sparingly to the affected area, typically after defaecation and at night, and review rather than continue indefinitely if symptoms do not settle.
  • Lidocaine sensitivity in the perianal skin is recognised; stop if local irritation, rash or worsening symptoms develop and reconsider the diagnosis.

Monitoring

No routine laboratory monitoring is needed for short topical use; review symptom response and local tolerability and reassess if there is no improvement.

Counselling the patient

  • Use only for the short course advised and apply a thin amount to the affected area, washing your hands afterwards.
  • Seek review if bleeding, severe pain or symptoms persist, as these may need further assessment.

Evidence & guidelines

Combined corticosteroid–local anaesthetic anorectal preparations are long-established for symptomatic relief; UK guidance and the SPC emphasise short-term use alongside conservative measures.

Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.